Should I buy or sell Dr. Agarwal's Eye Hospital?

The average broker rating on Dr. Agarwal's Eye Hospital is Buy. The breakup of analyst rating is given below - 0.00 analysts have given a strong sell rating 0.00 analysts have given a sell rating 1 analysts have given a hold rating 1 analysts have given a buy rating 1 analysts have given a strong buy rating

Is Dr. Agarwal's Eye Hospital a good stock to invest in?

Dr. Agarwal's Eye Hospital can be analyzed on the following key metrics - TTM P/E: 56.15 Sector P/E: 23.18 Dividend Yield: 0.12% D/E ratio: -

Dr. Agarwal's Eye Hospital Share Price

Sector: Healthcare Facilities

Powered by

4086.00 -34.25 (-0.83%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 4080.00

Today’s High 4196.95

52 Week Low 2800.00

52 Week High 7300.00

Key Metrics

Market Cap (In Cr) 1907.16
Beta 0.06
Div. Yield (%) 0.12
P/B 12.27
TTM P/E 56.15
Sector P/E 23.18
Open Price 4148.9
Prev Close 4120.25

View All Metrics

Dr. Agarwal's Eye Hospital Analysis

Price Analysis

1 Week

2.52%
3 Months

0.9%
6 Month

-17.1%
YTD

-33.28%
1 Year

18.15%

Risk Meter

59% Low risk
59% Moderate risk
59% Balanced Risk
59% High risk
59% Extreme risk

Recos

Strong Sell
Sell
Hold
Buy
Strong Buy

Analysts' Views

Ratings
Current
1 W Ago
1 M Ago
3 M Ago

Strong Buy
1
1
1
0.00

Buy
1
0.00
0.00
0.00

Hold
1
1
0.00
0.00

Sell
0.00
0.00
0.00
0.00

Strong Sell
0.00
0.00
0.00
0.00

Total
3
2
1
0.00

Dr. Agarwal's Eye Hospital News

Dr. Agarwal’s Health Care IPO will open for subscription on Wednesday and close on Friday. (Image: Pixabay)

Premium

Dr. Agarwal's Health Care IPO: Is a clearer vision on the horizon?

4 min read . 29 Jan 2025

Stock market today: Sumeet Bagadia believes the overall outlook for the Indian stock market is sideways to positive. (PHOTO: MINT)

Premium

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

2 min read . 10 Jan 2025

$Dividend stocks: Reliance Industries, Man Infraconstruction among 4 stocks to trade ex-dividend on August 19$ Premium

Dividend stocks: RIL, Man Infra among 4 stocks to trade ex-dividend on August 19

1 min read . 19 Aug 2024

Besides eye hospitals, Aditya Jyot will open over 100 outreach clinics in the next three years,

Premium

Dr Agarwals Eye Hospitals invest over ₹300 crores in Maha to set up hospitals

1 min read . 08 Oct 2021

View More News

Dr. Agarwal's Eye Hospital Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
319.3

Selling/ General/ Admin Expenses Total
125.75

Depreciation/ Amortization
26.61

Other Operating Expenses Total
24.39

Total Operating Expense
252.9

Operating Income
66.4

Net Income Before Taxes
62.25

Net Income
46.36

Diluted Normalized EPS
99

Period
2023

Total Revenue
267.89

Selling/ General/ Admin Expenses Total
127.18

Depreciation/ Amortization
20.18

Other Operating Expenses Total
1.66

Total Operating Expense
213.27

Operating Income
54.62

Net Income Before Taxes
49.4

Net Income
36.92

Diluted Normalized EPS
78.51

Period
2022

Total Revenue
201.21

Selling/ General/ Admin Expenses Total
92.39

Depreciation/ Amortization
20.39

Other Operating Expenses Total
1.98

Total Operating Expense
163.92

Operating Income
37.29

Net Income Before Taxes
32.31

Net Income
24.1

Diluted Normalized EPS
51.29

Period
2021

Total Revenue
139.81

Selling/ General/ Admin Expenses Total
73.56

Depreciation/ Amortization
19.1

Other Operating Expenses Total
1.34

Total Operating Expense
128.51

Operating Income
11.3

Net Income Before Taxes
5.73

Net Income
-1.44

Diluted Normalized EPS
-3.03

Period
2020

Total Revenue
175.95

Selling/ General/ Admin Expenses Total
86.01

Depreciation/ Amortization
21.24

Other Operating Expenses Total
1.26

Total Operating Expense
150.85

Operating Income
25.11

Net Income Before Taxes
19.94

Net Income
13.68

Diluted Normalized EPS
28.68

Period
2019

Total Revenue
170.05

Selling/ General/ Admin Expenses Total
97.88

Depreciation/ Amortization
10.91

Other Operating Expenses Total
2.45

Total Operating Expense
152.02

Operating Income
18.02

Net Income Before Taxes
17.43

Net Income
11.92

Diluted Normalized EPS
25.31

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Dr. Agarwal's Eye Hospital Technical

Moving Average SMA

5 Day4107.93
10 Day4093.72
20 Day4177.2

50 Day4191.99
100 Day4800.73
300 Day4716.46

Dr. Agarwal's Eye Hospital Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Shalby
195.95
-0.15
-0.08
325
177.25
2128.93

Krsnaa Diagnostics
647.2
-25.9
-3.85
1041.8
527.55
2090.1

Dr. Agarwal's Eye Hospital
4086
-34.25
-0.83
7300
2800
1907.16

Gpt Healthcare
160.65
1.35
0.85
206.5
126.15
1320.69

Kerala Ayurveda
425
22.15
5.5
486.9
250
515.03

Dr. Agarwal's Eye Hospital Shareholding

Shareholding Pattern

*Promoter pledging: 39.87%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-Feb-25
Quarterly Results

25-Jul-24
Quarterly Results

25-Apr-24
Audited Results & Final Dividend

18-Jan-24
Quarterly Results

20-Oct-23
Quarterly Results & Interim Dividend

04-Aug-23
Quarterly Results

06-May-23
Audited Results & Dividend

21-Jan-23
Quarterly Results

07-Nov-22
Quarterly Results

28-Oct-22
Quarterly Results

Meeting Date
Announced on
Purpose

03-Dec-24
04-Nov-24
POM

26-Aug-24
05-Aug-24
AGM

21-Sept-23
30-Aug-23
AGM

Announced on
Record Date
Ex-Dividend
Dividend Value

24-Oct-24
08-Nov-24
08-Nov-24
2.5

25-Apr-24
-
19-Aug-24
2.5

13-Oct-23
31-Oct-23
31-Oct-23
2.5

28-Apr-23
-
14-Sept-23
3

04-May-22
-
06-Sept-22
3

View All

Company Profile

ABOUT Dr. Agarwal's Eye Hospital

Industry Healthcare Facilities
ISIN INE934C01018
BSE Code 526783

Dr. Agarwal's Eye Hospital Limited is an India-based company engaged in running, owning and managing eye care hospitals, optical, pharmacies, and related services. The Company provides eye anatomy & treatments, including retina, uvea, cornea, orbit, photocoagulation, vitrectomy, anti VEGF, dry eyes, scleral buckle, pre descemets endothelial keratoplasty (PDEK), refractive surgery and pediatric ophthalmology. It also provides treatment for cataract, glaucoma, squint, diabetic retinopathy, retinal detachment, retinopathy prematurity, macular edema, traumatic cataract, macular hole, posterior subcapsular cataract, rosette cataract and congenital glaucoma. The Company provides its services in various locations in India, including Tamil Nadu, Karnataka, Maharashtra, Kerala, West Bengal, Odisha, Andhra Pradesh, Pondicherry, Gujarat, Rajasthan, Madhya Pradesh, and Andaman.

MANAGEMENT

Amar Agarwal Executive and Non-Independent Chairman of the Board, Managing Director
Yashwanth Venkat Interim Chief Financial Officer
Meenakshi Jayaraman Compliance Officer, Company Secretary
Saradha Govindarajan Compliance Officer
Athiya Agarwal Non-Independent Whole Time Director
S. Lakshmi Narasimhan Company Secretary

DR. AGARWAL'S EYE HOSPITAL SUMMARY

Dr. Agarwal's Eye Hospital is trading 0.83% lower at Rs 4086.00 as compared to its last closing price. Dr. Agarwal's Eye Hospital has been trading in the price range of 4196.95 & 4080.00. Dr. Agarwal's Eye Hospital has given -33.28% in this year & 2.52% in the last 5 days.

Dr. Agarwal's Eye Hospital has TTM P/E ratio 56.15 as compared to the sector P/E of 23.18. There are 3 analysts who have initiated coverage on Dr. Agarwal's Eye Hospital. There are 1 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

The company posted a net profit of 10.4 Crores in its last quarter.

Listed peers of Dr. Agarwal's Eye Hospital include Shalby (-0.08%), Krsnaa Diagnostics (-3.85%), Dr. Agarwal's Eye Hospital (-0.83%) etc.

Dr. Agarwal's Eye Hospital has a 71.9% promoter holding & 28.1% public holding.

FAQs about Dr. Agarwal's Eye Hospital

Dr. Agarwal's Eye Hospital is trading at 4086.00 as on 16 May, 2025 3:29:52 PM. This is -0.83% lower as compared to its previous closing price of 4120.25

The market capitalization of Dr. Agarwal's Eye Hospital is 1907.16 Cr as on 16 May, 2025 3:29:52 PM.

The average broker rating on Dr. Agarwal's Eye Hospital is Buy. The breakup of analyst rating is given below -

0.00 analysts have given a strong sell rating
0.00 analysts have given a sell rating
1 analysts have given a hold rating
1 analysts have given a buy rating
1 analysts have given a strong buy rating

The 52 wk high for Dr. Agarwal's Eye Hospital is 7300.00 whereas the 52 wk low is 2800.00

Dr. Agarwal's Eye Hospital can be analyzed on the following key metrics -

TTM P/E: 56.15
Sector P/E: 23.18
Dividend Yield: 0.12%
D/E ratio: -

Dr. Agarwal's Eye Hospital reported a net profit of 46.36 Cr in 2024.

Dr. Agarwal's Eye Hospital Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Dr. Agarwal's Eye Hospital Share Price

Price Range

Key Metrics

Dr. Agarwal's Eye Hospital Analysis

Dr. Agarwal's Eye Hospital News

Dr. Agarwal's Health Care IPO: Is a clearer vision on the horizon?

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy

Dividend stocks: RIL, Man Infra among 4 stocks to trade ex-dividend on August 19

Dr Agarwals Eye Hospitals invest over ₹300 crores in Maha to set up hospitals

Dr. Agarwal's Eye Hospital Financials

Forecast

Forecast

Forecast

Dr. Agarwal's Eye Hospital Technical

Dr. Agarwal's Eye Hospital Peers

Dr. Agarwal's Eye Hospital Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Dr. Agarwal's Eye Hospital

MANAGEMENT

DR. AGARWAL'S EYE HOSPITAL SUMMARY

FAQs about Dr. Agarwal's Eye Hospital

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue